Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01522001
Other study ID # SHARED REHAB
Secondary ID
Status Completed
Phase Phase 4
First received January 26, 2012
Last updated May 28, 2015
Start date October 2011
Est. completion date April 2015

Study information

Verified date September 2012
Source University of Aarhus
Contact n/a
Is FDA regulated No
Health authority Denmark: The Regional Committee on Biomedical Research Ethics
Study type Interventional

Clinical Trial Summary

Cardiac rehabilitation is an individual adapted multidisciplinary intervention for people suffering from Heart Disease. It involves;

- Dietary counseling,

- Exercise training,

- Psychosocial support,

- Physician

- smoking cessation

- Patient education

The purpose is quick and complete recovery and to reduce the chance of recurrence.

In Denmark people admitted with Acute Cardiac Disease is referred to a course of hospital based cardiac rehabilitation at discharge.

The Danish Municipal Reform of 2007 changed the responsibility of rehabilitation from the Regions, who runs the hospitals, to the municipalities.

Shared care is in this setting that elements of treatment are completed different places in Health Care.

The aim of this study is:

- to establish a shared care model for Cardiac rehabilitation following admission with Acute Coronary Syndrome and

- to compare this model to the existing hospital based cardiac rehabilitation after admission with Acute Coronary Syndrome.

Primary outcome is participation in cardiac rehabilitation.


Recruitment information / eligibility

Status Completed
Enrollment 212
Est. completion date April 2015
Est. primary completion date April 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 79 Years
Eligibility Inclusion Criteria:

- Admission with Acute Coronary Syndrome

- Resident in district of Department of Cardiology, Aarhus University Hospital, Silkeborg or Viborg Hospital, part of the "Hospitalsenheden Midt" Viborg, Silkeborg, Skive, Hammel.

- Accept both models of cardiac rehabilitation

- written informed consent

Exclusion Criteria:

- Resident outside the district of Department of Cardiology, Aarhus University Hospital, Viborg Hospital or Silkeborg Hospital, part of "Hospitalsenheden Midt" (Viborg, Silkeborg, Skive, Hammel).

- Age 80 years or older

- Heart Failure (Ejection Fraction less than 40%)

- Severe Comorbidity

- Resuscitated and need of support from ergotherapist after discharge.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Behavioral:
Shared Care model
First visit at cardiac ambulatory approximately 14 days after discharge includes physician examination by cardiologist and counseling from nurse specialized in cardiac rehabilitation. Dietary counseling with dietician Exercise (1 hour, 2 timer pr week for 12 weeks) Smoking cessation if smoker with educated smoking cessation instructor Patient education and psychosocial support in 2 individual consultations and 8 group based consultations with experienced nurse Examination by the patient´s general practitioner 8-12 weeks after discharge.

Locations

Country Name City State
Denmark Aarhus University Hospital. Department of Cardiology and Medicine Aarhus
Denmark Silkeborg Hospital Silkeborg Region Midt
Denmark Viborg Hospital, Hospital Unit of Viborg, Silkeborg, Hammel and Skive Viborg

Sponsors (2)

Lead Sponsor Collaborator
University of Aarhus Region MidtJylland Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Participation in cardiac rehabilitation Participation in cardiac rehabilitation is evaluated for each element. Participation is defined as at least 50% for each element.
Smoking cessation
Dietary counseling
Exercise training
Physician
Patient education
Psychosocial support
Full participation is in 6 of 6 elements if smoker or 5/5 if non-smoker. Partial full participation is in 5/6 if smoker or 4/5 if non-smoker.
4 months No
Secondary Change of BMI and / or abdominal circumference 4 and 12 months No
Secondary 24-hour Ambulatory Blood Pressure 4 og 12 months No
Secondary Blood Cholesterol values (Total, LDL, HDL) 4 and 12 months No
Secondary Fasting Blood glucose 4 and 12 months No
Secondary Exercise Capacity 4 and 12 months No
Secondary Lifestyle changes Diet, Physical Activity, Smoking, Alcohol consumption. 4 and 12 months No
Secondary Depression score Estimated by Hospital Anxiety and Depression Scale 4 and 12 months No
Secondary Compliance to pharmaceutical treatment 4 and 12 months No
Secondary Readmission Total and cardiovascular 4 and 12 months No
Secondary Change in Health Related Quality of Living SF-12 HeartQoL EQ-5D 4 and 12 months No
Secondary Difference in Health economic costs 4 and 12 months No
See also
  Status Clinical Trial Phase
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06013813 - Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI N/A
Recruiting NCT05412927 - AngelMed Guardian® System PMA Post Approval Study
Completed NCT02750579 - Early or Delayed Revascularization for Intermediate and High-risk Non ST-elevation Acute Coronary Syndromes? N/A
Completed NCT04102410 - Assessing Force-velocity Profile: an Innovative Approach to Optimize Cardiac Rehabilitation in Coronary Patients N/A
Enrolling by invitation NCT03342131 - Serum Concentration of Wnt2 and Wnt4 in Patients With Acute Coronary Syndrome N/A
Recruiting NCT01218776 - International Survey of Acute Coronary Syndromes in Transitional Countries
Enrolling by invitation NCT04676100 - International CR Registry
Completed NCT03590535 - 5th Generation cTnT in ED ACS
Recruiting NCT05437900 - INSIGHTFUL-FFR Clinical Trial Phase 4
Completed NCT05551429 - Factors Related to Participation in Cardiac Rehabilitation in Patients With Acute Coronary Syndrome
Terminated NCT04316481 - IDE-ALERTS Continued Access Study N/A
Active, not recruiting NCT04475380 - Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
Not yet recruiting NCT04852146 - Electronic Feedback for Data Restitution and Valorization to the Emergency Teams in Aquitaine.
Active, not recruiting NCT02892903 - In the Management of Coronary Artery Disease, Does Routine Pressure Wire Assessment at the Time of Coronary Angiography Affect Management Strategy, Hospital Costs and Outcomes? N/A
Completed NCT04077229 - Piloting Text Messages to Promote Positive Affect and Physical Activity N/A
Not yet recruiting NCT02871622 - BMX Alpha Registry: a Post-market Registry of the BioMatrix Alpha TM N/A
Completed NCT02944123 - Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR) Phase 3
Active, not recruiting NCT02922140 - The Impact of Pharmaceutical Care Practice on Patients in Cardiac Rehabilitation Unit N/A
Completed NCT02673437 - Rivaroxaban ACS Specialist Cohort Event Monitoring Study